Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.
Pugnet G, Petermann A, Collot S, Otal P, Lansiaux P, Ait Abdallah N, Lorillon G, Resche-Rigon M, Borel C, Marjanovic Z, Farge D; MATHEC-SFGM-TC network. Pugnet G, et al. Among authors: collot s. Rheumatology (Oxford). 2023 Feb 6;62(SI):SI32-SI42. doi: 10.1093/rheumatology/keac319. Rheumatology (Oxford). 2023. PMID: 35686921 Free PMC article.
Hemostastic embolization in oncology.
Revel-Mouroz P, Mokrane FZ, Collot S, Chabbert V, Rousseau H, Meyrignac O, Otal P. Revel-Mouroz P, et al. Among authors: collot s. Diagn Interv Imaging. 2015 Jul-Aug;96(7-8):807-21. doi: 10.1016/j.diii.2015.06.008. Epub 2015 Jul 15. Diagn Interv Imaging. 2015. PMID: 26188637 Free article. Review.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot JM, Raimbourg J, Girard N, Guisier F, Planchard D, Metivier AC, Tomasini P, Dansin E, Pérol M, Campana M, Gautschi O, Früh M, Fumet JD, Audigier-Valette C, Couraud S, Dalle S, Leccia MT, Jaffro M, Collot S, Prévot G, Milia J, Mazieres J. Delaunay M, et al. Among authors: collot s. Eur Respir J. 2017 Aug 10;50(2):1700050. doi: 10.1183/13993003.00050-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28798088 Free article. Clinical Trial.
[Epidemiology of fibrosing interstitial lung diseases in the department of Haute Garonne].
Villeneuve T, Prévot G, Lintz F, Mourin G, Ferry G, Bousquet E, Perelroizen H, Boghanim T, Faviez G, Noël-Savina E, Collot S, Le Borgne A, Didier A. Villeneuve T, et al. Among authors: collot s. Rev Mal Respir. 2021 Dec;38(10):972-979. doi: 10.1016/j.rmr.2021.07.004. Epub 2021 Oct 8. Rev Mal Respir. 2021. PMID: 34629221 French.
[Toxicity of immune checkpoints inhibitors].
Delaunay M, Caron P, Sibaud V, Godillot C, Collot S, Milia J, Prévot G, Mazières J. Delaunay M, et al. Among authors: collot s. Rev Mal Respir. 2018 Dec;35(10):1028-1038. doi: 10.1016/j.rmr.2017.08.006. Epub 2018 Sep 10. Rev Mal Respir. 2018. PMID: 30213624 Review. French.
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.
Mazieres J, Cropet C, Montané L, Barlesi F, Souquet PJ, Quantin X, Dubos-Arvis C, Otto J, Favier L, Avrillon V, Cadranel J, Moro-Sibilot D, Monnet I, Westeel V, Le Treut J, Brain E, Trédaniel J, Jaffro M, Collot S, Ferretti GR, Tiffon C, Mahier-Ait Oukhatar C, Blay JY. Mazieres J, et al. Among authors: collot s. Ann Oncol. 2020 Feb;31(2):289-294. doi: 10.1016/j.annonc.2019.10.022. Epub 2020 Jan 3. Ann Oncol. 2020. PMID: 31959346 Free article.
22 results